Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Jul;97(Suppl 1):25–30.

Harmful and beneficial antibodies in immune thrombocytopenic purpura.

P A Imbach 1
PMCID: PMC1550381  PMID: 8033430

Abstract

Two facts support the definition of idiopathic thrombocytopenic purpura (ITP) as an immune disorder. First, antibodies against platelets, which often appear after a viral infection, provoke the increased elimination of these cells. Viral disease may change the complex immune response of the host at different levels. In chronic ITP, the consequences of the dysregulated immune system are autoantibodies, primarily against platelet glycoprotein IIb/IIIa. Second, pooled immunoglobulins from healthy blood donors may influence the imbalanced immune response in ITP. The initial study dose of 5 x 0.4 g of intact 7S IgG/kg body weight can now be reduced to 2 x 0.4 g/kg body weight in the majority of patients. The possible mechanisms of action of intravenous immune globulin (IVIG) are reviewed and updated in this article. The combination of effects on the humoral and cellular immune responses using IVIG in concert with cytokines may open up new therapeutic possibilities.

Full text

PDF
25

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson L. J., Török T. J. Human parvovirus B19. N Engl J Med. 1989 Aug 24;321(8):536–538. doi: 10.1056/NEJM198908243210809. [DOI] [PubMed] [Google Scholar]
  2. Andersson J. P., Andersson U. G. Human intravenous immunoglobulin modulates monokine production in vitro. Immunology. 1990 Nov;71(3):372–376. [PMC free article] [PubMed] [Google Scholar]
  3. Ballin A., Andrew M., Ling E., Perlman M., Blanchette V. High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr. 1988 May;112(5):789–792. doi: 10.1016/s0022-3476(88)80705-4. [DOI] [PubMed] [Google Scholar]
  4. Bettaieb A., Oksenhendler E., Fromont P., Duedari N., Bierling P. Immunochemical analysis of platelet autoantibodies in HIV-related thrombocytopenic purpura: a study of 68 patients. Br J Haematol. 1989 Oct;73(2):241–247. doi: 10.1111/j.1365-2141.1989.tb00259.x. [DOI] [PubMed] [Google Scholar]
  5. Chapman J. F., Metcalfe P., Murphy M. F., Burman J. F., Waters A. H. Sequential development of platelet, neutrophil and red cell autoantibodies associated with measles infection. Clin Lab Haematol. 1984;6(3):219–228. doi: 10.1111/j.1365-2257.1984.tb00547.x. [DOI] [PubMed] [Google Scholar]
  6. Clarkson S. B., Bussel J. B., Kimberly R. P., Valinsky J. E., Nachman R. L., Unkeless J. C. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N Engl J Med. 1986 May 8;314(19):1236–1239. doi: 10.1056/NEJM198605083141907. [DOI] [PubMed] [Google Scholar]
  7. Dammacco F., Iodice G., Campobasso N. Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effects on circulating T cell subsets and PWM-induced antibody synthesis in vitro. Br J Haematol. 1986 Jan;62(1):125–135. doi: 10.1111/j.1365-2141.1986.tb02908.x. [DOI] [PubMed] [Google Scholar]
  8. Dwyer J. M. Manipulating the immune system with immune globulin. N Engl J Med. 1992 Jan 9;326(2):107–116. doi: 10.1056/NEJM199201093260206. [DOI] [PubMed] [Google Scholar]
  9. Fateh-Moghadam A., Wick M., Besinger U., Geursen R. G. High-dose intravenous gammaglobulin for myasthenia gravis. Lancet. 1984 Apr 14;1(8381):848–849. doi: 10.1016/s0140-6736(84)92294-3. [DOI] [PubMed] [Google Scholar]
  10. Fehr J., Hofmann V., Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med. 1982 May 27;306(21):1254–1258. doi: 10.1056/NEJM198205273062102. [DOI] [PubMed] [Google Scholar]
  11. Foreman N. K., Oakhill A., Caul E. O. Parvovirus-associated thrombocytopenic purpura. Lancet. 1988 Dec 17;2(8625):1426–1427. doi: 10.1016/s0140-6736(88)90619-8. [DOI] [PubMed] [Google Scholar]
  12. Fujinami R. S., Nelson J. A., Walker L., Oldstone M. B. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol. 1988 Jan;62(1):100–105. doi: 10.1128/jvi.62.1.100-105.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Griffin D. E., Moench T. R., Johnson R. T., Lindo de Soriano I., Vaisberg A. Peripheral blood mononuclear cells during natural measles virus infection: cell surface phenotypes and evidence for activation. Clin Immunol Immunopathol. 1986 Aug;40(2):305–312. doi: 10.1016/0090-1229(86)90035-8. [DOI] [PubMed] [Google Scholar]
  14. HARRINGTON W. J., MINNICH V., HOLLINGSWORTH J. W., MOORE C. V. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951 Jul;38(1):1–10. [PubMed] [Google Scholar]
  15. Hanada T., Koike K., Takeya T., Nagasawa T., Matsunaga Y., Takita H. Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis. Br J Haematol. 1988 Sep;70(1):113–115. doi: 10.1111/j.1365-2141.1988.tb02442.x. [DOI] [PubMed] [Google Scholar]
  16. Imbach P., Barandun S., d'Apuzzo V., Baumgartner C., Hirt A., Morell A., Rossi E., Schöni M., Vest M., Wagner H. P. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981 Jun 6;1(8232):1228–1231. doi: 10.1016/s0140-6736(81)92400-4. [DOI] [PubMed] [Google Scholar]
  17. Imbach P., Tani P., Berchtold W., Blanchette V., Burek-Kozlowska A., Gerber H., Jacobs P., Newland A., Turner C., Wood L. Different forms of chronic childhood thrombocytopenic purpura defined by antiplatelet autoantibodies. J Pediatr. 1991 Apr;118(4 Pt 1):535–539. doi: 10.1016/s0022-3476(05)83373-6. [DOI] [PubMed] [Google Scholar]
  18. Imbach P., Wagner H. P., Berchtold W., Gaedicke G., Hirt A., Joller P., Mueller-Eckhardt C., Müller B., Rossi E., Barandun S. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet. 1985 Aug 31;2(8453):464–468. doi: 10.1016/s0140-6736(85)90400-3. [DOI] [PubMed] [Google Scholar]
  19. Imholz B., Imbach P., Baumgartner C., Berchtold W., Gaedicke G., Gugler E., Hirt A., Hitzig W., Mueller-Eckhardt C., Wagner H. P. Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: a prospective multicenter study. Blut. 1988 Feb;56(2):63–68. doi: 10.1007/BF00633464. [DOI] [PubMed] [Google Scholar]
  20. Karpatkin S., Nardi M., Lennette E. T., Byrne B., Poiesz B. Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9763–9767. doi: 10.1073/pnas.85.24.9763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Karpatkin S., Nardi M., Lennette E. T., Byrne B., Poiesz B. Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9763–9767. doi: 10.1073/pnas.85.24.9763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kelton J. G., Inwood M. J., Barr R. M., Effer S. B., Hunter D., Wilson W. E., Ginsburg D. A., Powers P. J. The prenatal prediction of thrombocytopenia in infants of mothers with clinically diagnosed immune thrombocytopenia. Am J Obstet Gynecol. 1982 Oct 15;144(4):449–454. doi: 10.1016/0002-9378(82)90252-6. [DOI] [PubMed] [Google Scholar]
  23. Kelton J. G. Management of the pregnant patient with idiopathic thrombocytopenic purpura. Ann Intern Med. 1983 Dec;99(6):796–800. doi: 10.7326/0003-4819-99-6-796. [DOI] [PubMed] [Google Scholar]
  24. Kiefel V., Santoso S., Weisheit M., Müeller-Eckhardt C. Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood. 1987 Dec;70(6):1722–1726. [PubMed] [Google Scholar]
  25. Klaassen R. J., Mulder J. W., Vlekke A. B., Eeftinck Schattenkerk J. K., Weigel H. M., Lange J. M., von dem Borne A. E. Autoantibodies against peripheral blood cells appear early in HIV infection and their prevalence increases with disease progression. Clin Exp Immunol. 1990 Jul;81(1):11–17. doi: 10.1111/j.1365-2249.1990.tb05284.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kurtzman G., Frickhofen N., Kimball J., Jenkins D. W., Nienhuis A. W., Young N. S. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med. 1989 Aug 24;321(8):519–523. doi: 10.1056/NEJM198908243210807. [DOI] [PubMed] [Google Scholar]
  27. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  28. Lefrère J. J., Couroucé A. M., Kaplan C. Parvovirus and idiopathic thrombocytopenic purpura. Lancet. 1989 Feb 4;1(8632):279–279. doi: 10.1016/s0140-6736(89)91290-7. [DOI] [PubMed] [Google Scholar]
  29. Martin J. N., Jr, Morrison J. C., Files J. C. Autoimmune thrombocytopenic purpura: current concepts and recommended practices. Am J Obstet Gynecol. 1984 Sep 1;150(1):86–96. doi: 10.1016/s0002-9378(84)80115-5. [DOI] [PubMed] [Google Scholar]
  30. McGuire W. A., Yang H. H., Bruno E., Brandt J., Briddell R., Coates T. D., Hoffman R. Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin. N Engl J Med. 1987 Oct 15;317(16):1004–1008. doi: 10.1056/NEJM198710153171606. [DOI] [PubMed] [Google Scholar]
  31. McMillan R., Tani P., Millard F., Berchtold P., Renshaw L., Woods V. L., Jr Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood. 1987 Oct;70(4):1040–1045. [PubMed] [Google Scholar]
  32. Newland A. C., Boots M. A., Patterson K. G. Intravenous IgG for autoimmune thrombocytopenia in pregnancy. N Engl J Med. 1984 Jan 26;310(4):261–262. doi: 10.1056/nejm198401263100416. [DOI] [PubMed] [Google Scholar]
  33. Rhodes G., Rumpold H., Kurki P., Patrick K. M., Carson D. A., Vaughan J. H. Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen. J Exp Med. 1987 Apr 1;165(4):1026–1040. doi: 10.1084/jem.165.4.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Samuels P., Bussel J. B., Braitman L. E., Tomaski A., Druzin M. L., Mennuti M. T., Cines D. B. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med. 1990 Jul 26;323(4):229–235. doi: 10.1056/NEJM199007263230404. [DOI] [PubMed] [Google Scholar]
  35. Sandilands G. P., Atrah H. I., Templeton G., Cocker J. E., Lucie N., Crawford R. J., MacSween R. N. In vivo and in vitro blocking of human lymphocyte Fc gamma-receptors by intravenous gammaglobulin. J Clin Lab Immunol. 1987 Jul;23(3):109–115. [PubMed] [Google Scholar]
  36. Shannon K. M., Ammann A. J. Acquired immune deficiency syndrome in childhood. J Pediatr. 1985 Feb;106(2):332–342. doi: 10.1016/s0022-3476(85)80320-6. [DOI] [PubMed] [Google Scholar]
  37. Sing G. K., Ruscetti F. W. Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood. 1990 May 15;75(10):1965–1973. [PubMed] [Google Scholar]
  38. Sultan Y., Kazatchkine M. D., Maisonneuve P., Nydegger U. E. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. 1984 Oct 6;2(8406):765–768. doi: 10.1016/s0140-6736(84)90701-3. [DOI] [PubMed] [Google Scholar]
  39. Sumimoto S., Kasajima Y., Hamamoto T., Miyanomae T., Iwai Y., Mayumi M., Mikawa H. Agranulocytosis following infectious mononucleosis. Eur J Pediatr. 1990 Jul;149(10):691–694. doi: 10.1007/BF01959523. [DOI] [PubMed] [Google Scholar]
  40. Sunyer J., Antó J. M., Rodrigo M. J., Morell F. Case-control study of serum immunoglobulin-E antibodies reactive with soybean in epidemic asthma. Lancet. 1989 Jan 28;1(8631):179–182. doi: 10.1016/s0140-6736(89)91201-4. [DOI] [PubMed] [Google Scholar]
  41. Walsh C. M., Nardi M. A., Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med. 1984 Sep 6;311(10):635–639. doi: 10.1056/NEJM198409063111004. [DOI] [PubMed] [Google Scholar]
  42. Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol. 1988 Apr;25(2):159–172. [PubMed] [Google Scholar]
  43. Young N., Mortimer P. Viruses and bone marrow failure. Blood. 1984 Apr;63(4):729–737. [PubMed] [Google Scholar]
  44. Zon L. I., Groopman J. E. Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol. 1988 Jul;25(3):208–218. [PubMed] [Google Scholar]
  45. van der Lelie J., Lange J. M., Vos J. J., van Dalen C. M., Danner S. A., von dem Borne A. E. Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection. Br J Haematol. 1987 Sep;67(1):109–114. doi: 10.1111/j.1365-2141.1987.tb02304.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES